The 2021-22 edition of U.S. News & World Report rankings put UCLA Medical Center in the No. 3 spot and Cedars-Sinai Medical Center in the No. 6 slot nationally.
ImmunityBio’s share price has headed almost entirely downhill, shedding 70% of its value in four months.
Biopharma company Kite will sell one of its drug platforms and a manufacturing facility in Maryland to BioNTech.
Uniper Care Technologies, a home-based senior services content provider headquartered in Tel Aviv, Israel, with its U.S. headquarters in Palms, has raised $14.5 million to expand its television-based platform in the United States.
Santa Monica-based immunotherapy company Kite, a subsidiary company of Foster City-based Gilead Sciences Inc., has signed one new drug development partnership and hit a key milestone with another.
Shares of Pasadena-based Arrowhead Pharmaceuticals Inc. plunged 34% on July 2 to $63.07 after the company halted trials of a drug to treat cystic fibrosis following reports of toxicity issues in tests of the drug on rats.
Incubators have long been viewed as crucial to jump-start the development of tech, life science and other companies.
Cerritos-based cancer treatment company Oncology Institute of Hope & Innovation announced that it intends to go public through a SPAC.
Marsh & McLennan Agency Survey: Tech Firms Re-imagine Employee Perks And Benefits In Response To The Pandemic
Tech companies are reacting to the post COVID-19 business environment by doing what they do best: Innovating to meet changing market dynamics.
Century City-based Vida Ventures, a life sciences investment fund co-founded by local biotech magnate and serial bioscience investor Arie Belldegrun, announced June 24 that it has closed its third fund after having raised $825 million from various institutional investors.
Cedars-Sinai Medical Center was awarded nearly $12 million from California’s stem cell agency for an ALS clinical trial.
Arrowhead Pharmaceuticals Inc. has signed a licensing deal with an Irish pharmaceutical company for drug to treat gout.
A new immunotherapy biotech company has set up its U.S. headquarters in Belldegrun’s former haunt, the old Kite Pharma building in Santa Monica.
Two local institutions in recent weeks have received funds for research and education.
Three local companies have made strides in recent weeks in their efforts to bring new Covid vaccines to market.